Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies

EJ Stohs, A Abbas, A Freifeld - Transplant Infectious Disease, 2024 - Wiley Online Library
Febrile neutropenia (FN) is common among hematologic malignancy patients, including
recipients of hematopoietic cell transplantation (HCT) and cellular therapies such as …

Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring

K Oda, A Yamaguchi, N Matsumoto… - Therapeutic Drug …, 2024 - journals.lww.com
Background: Optimal cefepime dosing is a challenge because of its dose-dependent
neurotoxicity. This study aimed to determine individualized cefepime dosing for febrile …

Bacterial Infections Post Stem Cell Transplant

SK Sharma - Basics of Hematopoietic Stem Cell Transplant, 2023 - Springer
Patients undergoing hematopoietic stem cell transplantation (SCT) are at high risk of
infections due to compromised immune systems. Both innate and adaptive components of …

[HTML][HTML] In the management of febrile neutropenia; evaluation of the factors affecting the lenght of hospital stay

F Yılmaz, B Sağlam, MR Aras, HBA Öztürk… - Turkish Journal of …, 2023 - dergipark.org.tr
Aim: Febrile neutropenia (FEN) is one of the most serious and commonly seen
complications of patients receiving chemotherapy for a diagnosis of hematological …

[PDF][PDF] Febril nötropeni yönetiminde yatı süresine etki eden faktörlerin değerlendirilmesi

F Ylmaz, B Saglam, MR Aras, AMY Gulccek… - scholar.archive.org
Öz Amaç: Febril nötropeni (FEN); kemoterapi alan hematolojik malignite tanılı hastalarda en
yaygın karılaılan ve en ciddi komplikasyonlardandır.. FEN; özellikle antimikrobiyal dirençli …

[引用][C] Fiebre en pacientes inmunodeprimidos

D Weir-Restrepo, M Zuluaga-Gómez, CMà Ardila - Revista Cubana de Medicina …, 2023